Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Balchem (BCPC)

Balchem Q3 net sales rise 8.6% to $290.7 million; GAAP EPS $1.46 vs $1.24

Positive Impact 3 of 5 earnings

Balchem reported results for the quarter ended September 30, 2026, with net sales of $290.7 million, up 8.6% from the prior year quarter, and GAAP net earnings of $46.7 million, up 16.0%. Diluted GAAP earnings per share were $1.46 versus $1.24, and all three reporting segments grew sales and earnings from operations, which points to improving results for shareholders.

Key points

  • Net sales were $290.7 million, up 8.6%; GAAP net earnings were $46.7 million, up 16.0%.
  • GAAP diluted EPS was $1.46 versus $1.24; adjusted EPS was $1.57 versus $1.35.
  • Free cash flow was $57.9 million; the company repurchased about $28 million of common stock in the quarter.
  • Net debt was $57.7 million with a leverage ratio of 0.2 times on a net debt basis.

The filing

CompanyBalchem (BCPC)
Form8-K, current report
Filed with the SECOct 23, 2026, 7:21 AM ET
Accession number0000009326-26-000032

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:17 PM ET, from the text of the filing and its press-release exhibits only.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.